Report Overview
Vaccines are biological entity used to activate acquired immunity to control or prevent particular disease or a group of disease. Immunization is carried out in infants as well as in adults. Vaccination against various bacterial and viral diseases is an integral part of infectious disease control world-wide.
The global Disease Control And Prevention Vaccine market size was estimated at USD 50870.0 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 10.40% during the forecast period.
This report provides a deep insight into the global Disease Control And Prevention Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Disease Control And Prevention Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Disease Control And Prevention Vaccine market in any manner.
Global Disease Control And Prevention Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
GSK
Merck & Co., Inc
Pfizer
Sanofi
AstraZeneca PLC
Sinovac Biotech Ltd
Astellas Pharma Inc
Serum Institute of India Pvt. Ltd
Daiichi Sankyo
Abbott Laboratories
Bharat Biotech International
Bavarian Nordic A/S
CSL Limited
Emergent BioSolutions Inc
Inovio Pharmaceuticals Inc
Johnson & Johnson
Mitsubishi Tanabe Pharma Corporation
Novavax Inc
Panacea Biotec Ltd
Takeda Pharmaceutical Company Limited
Market Segmentation (by Type)
Live-Attenuated
Inactivated
Recombinant Sub Unit and Toxoid
Market Segmentation (by Application)
Pediatric Vaccine
Adult Vaccine
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Disease Control And Prevention Vaccine Market
Overview of the regional outlook of the Disease Control And Prevention Vaccine Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Disease Control And Prevention Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Disease Control And Prevention Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
- 1 Research Methodology And Statistical Scope
- 1.1 Market Definition And Statistical Scope Of Disease Control And Prevention Vaccine
- 1.2 Key Market Segments
- 1.2.1 Disease Control And Prevention Vaccine Segment By Type
- 1.2.2 Disease Control And Prevention Vaccine Segment By Application
- 1.3 Methodology & Sources Of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown And Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Disease Control And Prevention Vaccine Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Disease Control And Prevention Vaccine Market Size (M Usd) Estimates And Forecasts (2020-2033)
- 2.1.2 Global Disease Control And Prevention Vaccine Sales Estimates And Forecasts (2020-2033)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size By Region
- 3 Disease Control And Prevention Vaccine Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Disease Control And Prevention Vaccine Product Life Cycle
- 3.3 Global Disease Control And Prevention Vaccine Sales By Manufacturers (2020-2025)
- 3.4 Global Disease Control And Prevention Vaccine Revenue Market Share By Manufacturers (2020-2025)
- 3.5 Disease Control And Prevention Vaccine Market Share By Company Type (Tier 1, Tier 2, And Tier 3)
- 3.6 Global Disease Control And Prevention Vaccine Average Price By Manufacturers (2020-2025)
- 3.7 Manufacturers’ Manufacturing Sites, Areas Served, And Product Types
- 3.8 Disease Control And Prevention Vaccine Market Competitive Situation And Trends
- 3.8.1 Disease Control And Prevention Vaccine Market Concentration Rate
- 3.8.2 Global 5 And 10 Largest Disease Control And Prevention Vaccine Players Market Share By Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 Disease Control And Prevention Vaccine Industry Chain Analysis
- 4.1 Disease Control And Prevention Vaccine Industry Chain Analysis
- 4.2 Market Overview Of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development And Dynamics Of Disease Control And Prevention Vaccine Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 Pest Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global Disease Control And Prevention Vaccine Market Porter's Five Forces Analysis
- 5.6.1 Global Trade Frictions
- 5.6.2 U.S. Tariff Policy – April 2025
- 5.6.3 Global Trade Frictions And Their Impacts To Disease Control And Prevention Vaccine Market
- 5.7 Esg Ratings Of Leading Companies
- 6 Disease Control And Prevention Vaccine Market Segmentation By Type
- 6.1 Evaluation Matrix Of Segment Market Development Potential (Type)
- 6.2 Global Disease Control And Prevention Vaccine Sales Market Share By Type (2020-2025)
- 6.3 Global Disease Control And Prevention Vaccine Market Size Market Share By Type (2020-2025)
- 6.4 Global Disease Control And Prevention Vaccine Price By Type (2020-2025)
- 7 Disease Control And Prevention Vaccine Market Segmentation By Application
- 7.1 Evaluation Matrix Of Segment Market Development Potential (Application)
- 7.2 Global Disease Control And Prevention Vaccine Market Sales By Application (2020-2025)
- 7.3 Global Disease Control And Prevention Vaccine Market Size (M Usd) By Application (2020-2025)
- 7.4 Global Disease Control And Prevention Vaccine Sales Growth Rate By Application (2020-2025)
- 8 Disease Control And Prevention Vaccine Market Sales By Region
- 8.1 Global Disease Control And Prevention Vaccine Sales By Region
- 8.1.1 Global Disease Control And Prevention Vaccine Sales By Region
- 8.1.2 Global Disease Control And Prevention Vaccine Sales Market Share By Region
- 8.2 Global Disease Control And Prevention Vaccine Market Size By Region
- 8.2.1 Global Disease Control And Prevention Vaccine Market Size By Region
- 8.2.2 Global Disease Control And Prevention Vaccine Market Size Market Share By Region
- 8.3 North America
- 8.3.1 North America Disease Control And Prevention Vaccine Sales By Country
- 8.3.2 North America Disease Control And Prevention Vaccine Market Size By Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe Disease Control And Prevention Vaccine Sales By Country
- 8.4.2 Europe Disease Control And Prevention Vaccine Market Size By Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Disease Control And Prevention Vaccine Sales By Region
- 8.5.2 Asia Pacific Disease Control And Prevention Vaccine Market Size By Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America Disease Control And Prevention Vaccine Sales By Country
- 8.6.2 South America Disease Control And Prevention Vaccine Market Size By Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East And Africa
- 8.7.1 Middle East And Africa Disease Control And Prevention Vaccine Sales By Region
- 8.7.2 Middle East And Africa Disease Control And Prevention Vaccine Market Size By Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 Uae Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 9 Disease Control And Prevention Vaccine Market Production By Region
- 9.1 Global Production Of Disease Control And Prevention Vaccine By Region(2020-2025)
- 9.2 Global Disease Control And Prevention Vaccine Revenue Market Share By Region (2020-2025)
- 9.3 Global Disease Control And Prevention Vaccine Production, Revenue, Price And Gross Margin (2020-2025)
- 9.4 North America Disease Control And Prevention Vaccine Production
- 9.4.1 North America Disease Control And Prevention Vaccine Production Growth Rate (2020-2025)
- 9.4.2 North America Disease Control And Prevention Vaccine Production, Revenue, Price And Gross Margin (2020-2025)
- 9.5 Europe Disease Control And Prevention Vaccine Production
- 9.5.1 Europe Disease Control And Prevention Vaccine Production Growth Rate (2020-2025)
- 9.5.2 Europe Disease Control And Prevention Vaccine Production, Revenue, Price And Gross Margin (2020-2025)
- 9.6 Japan Disease Control And Prevention Vaccine Production (2020-2025)
- 9.6.1 Japan Disease Control And Prevention Vaccine Production Growth Rate (2020-2025)
- 9.6.2 Japan Disease Control And Prevention Vaccine Production, Revenue, Price And Gross Margin (2020-2025)
- 9.7 China Disease Control And Prevention Vaccine Production (2020-2025)
- 9.7.1 China Disease Control And Prevention Vaccine Production Growth Rate (2020-2025)
- 9.7.2 China Disease Control And Prevention Vaccine Production, Revenue, Price And Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 Gsk
- 10.1.1 Gsk Basic Information
- 10.1.2 Gsk Disease Control And Prevention Vaccine Product Overview
- 10.1.3 Gsk Disease Control And Prevention Vaccine Product Market Performance
- 10.1.4 Gsk Business Overview
- 10.1.5 Gsk Swot Analysis
- 10.1.6 Gsk Recent Developments
- 10.2 Merck And Co., Inc
- 10.2.1 Merck And Co., Inc Basic Information
- 10.2.2 Merck And Co., Inc Disease Control And Prevention Vaccine Product Overview
- 10.2.3 Merck And Co., Inc Disease Control And Prevention Vaccine Product Market Performance
- 10.2.4 Merck And Co., Inc Business Overview
- 10.2.5 Merck And Co., Inc Swot Analysis
- 10.2.6 Merck And Co., Inc Recent Developments
- 10.3 Pfizer
- 10.3.1 Pfizer Basic Information
- 10.3.2 Pfizer Disease Control And Prevention Vaccine Product Overview
- 10.3.3 Pfizer Disease Control And Prevention Vaccine Product Market Performance
- 10.3.4 Pfizer Business Overview
- 10.3.5 Pfizer Swot Analysis
- 10.3.6 Pfizer Recent Developments
- 10.4 Sanofi
- 10.4.1 Sanofi Basic Information
- 10.4.2 Sanofi Disease Control And Prevention Vaccine Product Overview
- 10.4.3 Sanofi Disease Control And Prevention Vaccine Product Market Performance
- 10.4.4 Sanofi Business Overview
- 10.4.5 Sanofi Recent Developments
- 10.5 Astrazeneca Plc
- 10.5.1 Astrazeneca Plc Basic Information
- 10.5.2 Astrazeneca Plc Disease Control And Prevention Vaccine Product Overview
- 10.5.3 Astrazeneca Plc Disease Control And Prevention Vaccine Product Market Performance
- 10.5.4 Astrazeneca Plc Business Overview
- 10.5.5 Astrazeneca Plc Recent Developments
- 10.6 Sinovac Biotech Ltd
- 10.6.1 Sinovac Biotech Ltd Basic Information
- 10.6.2 Sinovac Biotech Ltd Disease Control And Prevention Vaccine Product Overview
- 10.6.3 Sinovac Biotech Ltd Disease Control And Prevention Vaccine Product Market Performance
- 10.6.4 Sinovac Biotech Ltd Business Overview
- 10.6.5 Sinovac Biotech Ltd Recent Developments
- 10.7 Astellas Pharma Inc
- 10.7.1 Astellas Pharma Inc Basic Information
- 10.7.2 Astellas Pharma Inc Disease Control And Prevention Vaccine Product Overview
- 10.7.3 Astellas Pharma Inc Disease Control And Prevention Vaccine Product Market Performance
- 10.7.4 Astellas Pharma Inc Business Overview
- 10.7.5 Astellas Pharma Inc Recent Developments
- 10.8 Serum Institute Of India Pvt. Ltd
- 10.8.1 Serum Institute Of India Pvt. Ltd Basic Information
- 10.8.2 Serum Institute Of India Pvt. Ltd Disease Control And Prevention Vaccine Product Overview
- 10.8.3 Serum Institute Of India Pvt. Ltd Disease Control And Prevention Vaccine Product Market Performance
- 10.8.4 Serum Institute Of India Pvt. Ltd Business Overview
- 10.8.5 Serum Institute Of India Pvt. Ltd Recent Developments
- 10.9 Daiichi Sankyo
- 10.9.1 Daiichi Sankyo Basic Information
- 10.9.2 Daiichi Sankyo Disease Control And Prevention Vaccine Product Overview
- 10.9.3 Daiichi Sankyo Disease Control And Prevention Vaccine Product Market Performance
- 10.9.4 Daiichi Sankyo Business Overview
- 10.9.5 Daiichi Sankyo Recent Developments
- 10.10 Abbott Laboratories
- 10.10.1 Abbott Laboratories Basic Information
- 10.10.2 Abbott Laboratories Disease Control And Prevention Vaccine Product Overview
- 10.10.3 Abbott Laboratories Disease Control And Prevention Vaccine Product Market Performance
- 10.10.4 Abbott Laboratories Business Overview
- 10.10.5 Abbott Laboratories Recent Developments
- 10.11 Bharat Biotech International
- 10.11.1 Bharat Biotech International Basic Information
- 10.11.2 Bharat Biotech International Disease Control And Prevention Vaccine Product Overview
- 10.11.3 Bharat Biotech International Disease Control And Prevention Vaccine Product Market Performance
- 10.11.4 Bharat Biotech International Business Overview
- 10.11.5 Bharat Biotech International Recent Developments
- 10.12 Bavarian Nordic A/S
- 10.12.1 Bavarian Nordic A/S Basic Information
- 10.12.2 Bavarian Nordic A/S Disease Control And Prevention Vaccine Product Overview
- 10.12.3 Bavarian Nordic A/S Disease Control And Prevention Vaccine Product Market Performance
- 10.12.4 Bavarian Nordic A/S Business Overview
- 10.12.5 Bavarian Nordic A/S Recent Developments
- 10.13 Csl Limited
- 10.13.1 Csl Limited Basic Information
- 10.13.2 Csl Limited Disease Control And Prevention Vaccine Product Overview
- 10.13.3 Csl Limited Disease Control And Prevention Vaccine Product Market Performance
- 10.13.4 Csl Limited Business Overview
- 10.13.5 Csl Limited Recent Developments
- 10.14 Emergent Biosolutions Inc
- 10.14.1 Emergent Biosolutions Inc Basic Information
- 10.14.2 Emergent Biosolutions Inc Disease Control And Prevention Vaccine Product Overview
- 10.14.3 Emergent Biosolutions Inc Disease Control And Prevention Vaccine Product Market Performance
- 10.14.4 Emergent Biosolutions Inc Business Overview
- 10.14.5 Emergent Biosolutions Inc Recent Developments
- 10.15 Inovio Pharmaceuticals Inc
- 10.15.1 Inovio Pharmaceuticals Inc Basic Information
- 10.15.2 Inovio Pharmaceuticals Inc Disease Control And Prevention Vaccine Product Overview
- 10.15.3 Inovio Pharmaceuticals Inc Disease Control And Prevention Vaccine Product Market Performance
- 10.15.4 Inovio Pharmaceuticals Inc Business Overview
- 10.15.5 Inovio Pharmaceuticals Inc Recent Developments
- 10.16 Johnson And Johnson
- 10.16.1 Johnson And Johnson Basic Information
- 10.16.2 Johnson And Johnson Disease Control And Prevention Vaccine Product Overview
- 10.16.3 Johnson And Johnson Disease Control And Prevention Vaccine Product Market Performance
- 10.16.4 Johnson And Johnson Business Overview
- 10.16.5 Johnson And Johnson Recent Developments
- 10.17 Mitsubishi Tanabe Pharma Corporation
- 10.17.1 Mitsubishi Tanabe Pharma Corporation Basic Information
- 10.17.2 Mitsubishi Tanabe Pharma Corporation Disease Control And Prevention Vaccine Product Overview
- 10.17.3 Mitsubishi Tanabe Pharma Corporation Disease Control And Prevention Vaccine Product Market Performance
- 10.17.4 Mitsubishi Tanabe Pharma Corporation Business Overview
- 10.17.5 Mitsubishi Tanabe Pharma Corporation Recent Developments
- 10.18 Novavax Inc
- 10.18.1 Novavax Inc Basic Information
- 10.18.2 Novavax Inc Disease Control And Prevention Vaccine Product Overview
- 10.18.3 Novavax Inc Disease Control And Prevention Vaccine Product Market Performance
- 10.18.4 Novavax Inc Business Overview
- 10.18.5 Novavax Inc Recent Developments
- 10.19 Panacea Biotec Ltd
- 10.19.1 Panacea Biotec Ltd Basic Information
- 10.19.2 Panacea Biotec Ltd Disease Control And Prevention Vaccine Product Overview
- 10.19.3 Panacea Biotec Ltd Disease Control And Prevention Vaccine Product Market Performance
- 10.19.4 Panacea Biotec Ltd Business Overview
- 10.19.5 Panacea Biotec Ltd Recent Developments
- 10.20 Takeda Pharmaceutical Company Limited
- 10.20.1 Takeda Pharmaceutical Company Limited Basic Information
- 10.20.2 Takeda Pharmaceutical Company Limited Disease Control And Prevention Vaccine Product Overview
- 10.20.3 Takeda Pharmaceutical Company Limited Disease Control And Prevention Vaccine Product Market Performance
- 10.20.4 Takeda Pharmaceutical Company Limited Business Overview
- 10.20.5 Takeda Pharmaceutical Company Limited Recent Developments
- 11 Disease Control And Prevention Vaccine Market Forecast By Region
- 11.1 Global Disease Control And Prevention Vaccine Market Size Forecast
- 11.2 Global Disease Control And Prevention Vaccine Market Forecast By Region
- 11.2.1 North America Market Size Forecast By Country
- 11.2.2 Europe Disease Control And Prevention Vaccine Market Size Forecast By Country
- 11.2.3 Asia Pacific Disease Control And Prevention Vaccine Market Size Forecast By Region
- 11.2.4 South America Disease Control And Prevention Vaccine Market Size Forecast By Country
- 11.2.5 Middle East And Africa Forecasted Sales Of Disease Control And Prevention Vaccine By Country
- 12 Forecast Market By Type And By Application (2026-2033)
- 12.1 Global Disease Control And Prevention Vaccine Market Forecast By Type (2026-2033)
- 12.1.1 Global Forecasted Sales Of Disease Control And Prevention Vaccine By Type (2026-2033)
- 12.1.2 Global Disease Control And Prevention Vaccine Market Size Forecast By Type (2026-2033)
- 12.1.3 Global Forecasted Price Of Disease Control And Prevention Vaccine By Type (2026-2033)
- 12.2 Global Disease Control And Prevention Vaccine Market Forecast By Application (2026-2033)
- 12.2.1 Global Disease Control And Prevention Vaccine Sales (K Mt) Forecast By Application
- 12.2.2 Global Disease Control And Prevention Vaccine Market Size (M Usd) Forecast By Application (2026-2033)
- 13 Conclusion And Key Findings
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook